Top Markets
Coin of the day
W World Corp. W World Corp.

W World Corp.

WWHC
Rang in aandelen #22981
W World Corp. is a biopharmaceutical firm dedicated to identifying and... W World Corp. is a biopharmaceutical firm dedicated to identifying and advancing innovative treatments for various metabolic and neurological conditions. Its research and development efforts specifically target ailments related to the brain-gut axis, pain and inflammation, autoimmune diseases, and gout. The company's pipeline features two primary experimental drugs: Levotofisopam, currently in clinical trials as a non-sedative therapy for Gout, and Dextofisopam, a non-serotonergic compound that has successfully concluded Phase IIa and Phase IIb clinical trials for irritable bowel syndrome (IBS). Established in 1990, W World Corp. maintains its corporate headquarters in North Las Vegas, Nevada.
Aandeelprijs
$0.8
Laatst gesynchroniseerd: 2024-01-02
Marktkapitalisatie
$80.24M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel W World Corp. (WWHC)
Dividendrendementgeschiedenis voor W World Corp. (WWHC)
Het dividendrendement (TTM) van W World Corp. (aandelsymbool: WWHC) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van W World Corp. (WWHC) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten